Company intelligence / Profile preview

Z-Omics

Hong Kong, Hong Kongpmc.ncbi.nlm.nih.gov ↗

Ownership: Private
Development stage: Commercial

Overview

Z‑Omics is a Hong Kong-based biotech startup specializing in high-throughput single-cell multiomic platform technologies. Their proprietary IP enables robust and versatile applications across pharmaceutical research and other R&D settings. The company’s focus is on providing enabling tools for drug discovery and biomedical research rather than direct clinical programs or therapeutics.

Modalities: GenomicsTranscriptomicsProteomicsMetabolomics
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Z-Omics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Z-Omics.

Explore the full profile